SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023266
Filing Date
2017-11-09
Accepted
2017-11-09 16:24:45
Documents
51
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 SGMO-Q3-20170930 sgmo-10q_20170930.htm 10-Q 1424051
2 EX-31.1 sgmo-ex311_11.htm EX-31.1 15467
3 EX-31.2 sgmo-ex312_7.htm EX-31.2 15809
4 EX-32.1 sgmo-ex321_8.htm EX-32.1 7611
  Complete submission text file 0001564590-17-023266.txt   5199408

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sgmo-20170930.xml EX-101.INS 1229072
6 XBRL TAXONOMY EXTENSION SCHEMA sgmo-20170930.xsd EX-101.SCH 37835
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgmo-20170930_cal.xml EX-101.CAL 37934
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgmo-20170930_def.xml EX-101.DEF 120466
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmo-20170930_lab.xml EX-101.LAB 249502
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmo-20170930_pre.xml EX-101.PRE 203170
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 171191192
SIC: 2836 Biological Products, (No Diagnostic Substances)